Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global Complement-targeted Therapeutics Market Size study, By Indication (Paroxysmal Nocturnal Haemoglobinuria, Atypical Haemolytic Uraemic Syndrome (Ahus)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Regional Forecasts 2022-2028

  • BIZ4983005
  • 200 Pages
  • June 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Complement-targeted Therapeutics Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. The Complement-targeted Therapeutics can be defined as therapeutics that modulate the complement system. The complement system, also called as complement cascade, is a part of the immune system that enhances the ability of antibodies and phagocytic cells to clear microbes and damaged cells from an organism, and promote inflammation, as well as attack the pathogen's cell membrane. However, Activation of the complement system results in the pathogenesis of some diseases such as cancer, rheumatic diseases, Alzheimer's disease, autoimmune diseases, age-related macular degeneration, and schizophrenia among others. The increasing incidences of chronic diseases and growing number of clinical research in complement-targeted therapeutics as well as recent collaboration activities are factors that are accelerating the global market demand. For instance, according to World Health Organization – as of 2021, globally around 41 million people lost their lives due to Noncommunicable diseases (NCDs). NCDs are accounted for around 71% of all global deaths. IN NCDs Cardiovascular diseases account for largest number of deaths, or 17.9 million deaths, followed by cancers (9.3 million), respiratory diseases (4.1 million), and diabetes (1.5 million). Furthermore, in June 2021, Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Beam Therapeutics Inc. entered in a five-year research collaboration. Under this collaboration both the companies would utilize Beam’s proprietary base editing technology to discover new treatments for complement-driven diseases. The companies would work together on six research programs focused on C3 and other complement targets in the eye, liver, and brain. Also, growing prevalence of immune system diseases and rising healthcare infrastructure in emerging economies are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, lack of awareness towards complements deficiency and high treatment cost impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Complement-targeted Therapeutics market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to growing number of clinical trials and presence of leading market players in the region. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as rising healthcare infrastructure and increasing incidences of Noncommunicable diseases in the region, would create lucrative growth prospects for the Complement-targeted Therapeutics market across the Asia Pacific region.

Major market players included in this report are:

Creative Biolabs

Complement UK

Novartis Ag

Alexion Pharmaceuticals, Inc.

Merck & Co., Inc.

Pfizer Inc.

Allergan Plc.

Abbvie

Sino Biological Inc.

Cascade Biotechnology Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Indication

Paroxysmal Nocturnal Haemoglobinuria

Atypical Haemolytic Uraemic Syndrome (Ahus)

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global Complement-targeted Therapeutics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)

1.2.1. Global Complement-targeted Therapeutics Market, by Region, 2020-2028 (USD Million)

1.2.2. Global Complement-targeted Therapeutics Market, by Indication, 2020-2028 (USD Million)

1.2.3. Global Complement-targeted Therapeutics Market, by Distribution Channel, 2020-2028 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Complement-targeted Therapeutics Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Complement-targeted Therapeutics Market Dynamics

3.1. Complement-targeted Therapeutics Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Increasing incidences of chronic diseases.

3.1.1.2. Growing number of clinical research in complement-targeted therapeutics.

3.1.1.3. Recent collaboration activities.

3.1.2. Market Challenges

3.1.2.1. Lack of awareness towards complement deficiency.

3.1.2.2. High treatment cost.

3.1.3. Market Opportunities

3.1.3.1. Growing prevalence of immune system diseases

3.1.3.2. Rising healthcare infrastructure in emerging economies.

Chapter 4. Global Complement-targeted Therapeutics Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Complement-targeted Therapeutics Market, by Indication

6.1. Market Snapshot

6.2. Global Complement-targeted Therapeutics Market by Indication, Performance - Potential Analysis

6.3. Global Complement-targeted Therapeutics Market Estimates & Forecasts by Indication 2018-2028 (USD Million)

6.4. Complement-targeted Therapeutics Market, Sub Segment Analysis

6.4.1. Paroxysmal Nocturnal Haemoglobinuria

6.4.2. Atypical Haemolytic Uraemic Syndrome (Ahus)

Chapter 7. Global Complement-targeted Therapeutics Market, by Distribution Channel

7.1. Market Snapshot

7.2. Global Complement-targeted Therapeutics Market by Distribution Channel, Performance - Potential Analysis

7.3. Global Complement-targeted Therapeutics Market Estimates & Forecasts by Distribution Channel 2018-2028 (USD Million)

7.4. Complement-targeted Therapeutics Market, Sub Segment Analysis

7.4.1. Hospital Pharmacies

7.4.2. Retail Pharmacies

7.4.3. Online Pharmacies

Chapter 8. Global Complement-targeted Therapeutics Market, Regional Analysis

8.1. Complement-targeted Therapeutics Market, Regional Market Snapshot

8.2. North America Complement-targeted Therapeutics Market

8.2.1. U.S. Complement-targeted Therapeutics Market

8.2.1.1. Indication estimates & forecasts, 2018-2028

8.2.1.2. Distribution Channel estimates & forecasts, 2018-2028

8.2.2. Canada Complement-targeted Therapeutics Market

8.3. Europe Complement-targeted Therapeutics Market Snapshot

8.3.1. U.K. Complement-targeted Therapeutics Market

8.3.2. Germany Complement-targeted Therapeutics Market

8.3.3. France Complement-targeted Therapeutics Market

8.3.4. Spain Complement-targeted Therapeutics Market

8.3.5. Italy Complement-targeted Therapeutics Market

8.3.6. Rest of Europe Complement-targeted Therapeutics Market

8.4. Asia-Pacific Complement-targeted Therapeutics Market Snapshot

8.4.1. China Complement-targeted Therapeutics Market

8.4.2. India Complement-targeted Therapeutics Market

8.4.3. Japan Complement-targeted Therapeutics Market

8.4.4. Australia Complement-targeted Therapeutics Market

8.4.5. South Korea Complement-targeted Therapeutics Market

8.4.6. Rest of Asia Pacific Complement-targeted Therapeutics Market

8.5. Latin America Complement-targeted Therapeutics Market Snapshot

8.5.1. Brazil Complement-targeted Therapeutics Market

8.5.2. Mexico Complement-targeted Therapeutics Market

8.6. Rest of The World Complement-targeted Therapeutics Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies

9.2. Company Profiles

9.2.1. Creative Biolabs

9.2.1.1. Key Information

9.2.1.2. Overview

9.2.1.3. Financial (Subject to Data Availability)

9.2.1.4. Product Summary

9.2.1.5. Recent Developments

9.2.2. Complement UK

9.2.3. Novartis Ag

9.2.4. Alexion Pharmaceuticals, Inc.

9.2.5. Merck & Co., Inc.

9.2.6. Pfizer Inc.

9.2.7. Allergan Plc.

9.2.8. Abbvie

9.2.9. Sino Biological Inc.

9.2.10. Cascade Biotechnology Inc.

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.2. Research Attributes

10.3. Research Assumption

List of Tables

TABLE 1. Global Complement-targeted Therapeutics Market, report scope

TABLE 2. Global Complement-targeted Therapeutics Market estimates & forecasts by Region 2018-2028 (USD Million)

TABLE 3. Global Complement-targeted Therapeutics Market estimates & forecasts by Indication 2018-2028 (USD Million)

TABLE 4. Global Complement-targeted Therapeutics Market estimates & forecasts by Distribution Channel 2018-2028 (USD Million)

TABLE 5. Global Complement-targeted Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 6. Global Complement-targeted Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 7. Global Complement-targeted Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 8. Global Complement-targeted Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 9. Global Complement-targeted Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 10. Global Complement-targeted Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 11. Global Complement-targeted Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 12. Global Complement-targeted Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 13. Global Complement-targeted Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 14. Global Complement-targeted Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 15. U.S. Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 16. U.S. Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 17. U.S. Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 18. Canada Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 19. Canada Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 20. Canada Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 21. UK Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 22. UK Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 23. UK Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 24. Germany Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 25. Germany Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 26. Germany Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 27. RoE Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 28. RoE Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 29. RoE Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 30. China Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 31. China Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 32. China Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 33. India Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 34. India Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 35. India Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 36. Japan Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 37. Japan Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 38. Japan Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 39. RoAPAC Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 40. RoAPAC Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 41. RoAPAC Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 42. Brazil Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 43. Brazil Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 44. Brazil Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 45. Mexico Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 46. Mexico Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 47. Mexico Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 48. RoLA Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 49. RoLA Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 50. RoLA Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 51. Row Complement-targeted Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 52. Row Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 53. Row Complement-targeted Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 54. List of secondary sources, used in the study of global Complement-targeted Therapeutics Market

TABLE 55. List of primary sources, used in the study of global Complement-targeted Therapeutics Market

TABLE 56. Years considered for the study

TABLE 57. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
View Details
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370
View Details
Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

  • Publish Date: April 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research